Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kane BiotechKNBIF -0.55% Degree of Operating Leverage is 0.48 as of Mar. 2026. The stock has 6 warning signs investors should review. Among 853 Biotechnology companies, Kane Biotech ranks worse than 64.6% on this metric.
Degree of Operating Leverage (DOL) measures the percentage change in EBIT for a unit change in Revenue.
Kane Biotech's Degree of Operating Leverage for the quarter that ended in Mar. 2026 was 0.48. The higher Degree of Operating Leverage, the higher operating risk the company will take.
The industry rank for Kane Biotech's Degree of Operating Leverage or its related term are showing as below:
KNBIF's Degree of Operating Leverage is ranked worse than 64.6% of 853
companies
in the Biotechnology industry
Industry Median: -0.03
vs KNBIF: 0.48
Kane Biotech (OTCPK:KNBIF) Degree of Operating Leverage Explanation
Degree of Operating Leverage (DOL) is a leverage ratio that measures the sensitivity of a company’s operting income, also referred to as Earnings Before Interest and Taxes (EBIT), to fluctuations in its Revenue. DOL is a method used to quantify a company’s operating risk. This risk is related to the company's structure of variable costs and fixed costs. Since the fixed costs do not allow the company to adjust the operating costs, the operating risk rises with a higher fixed-to-variable costs proportion.
A high Degree of Operating Leverage indicates that the company’s fixed costs exceed its variable costs. By increasing the sales, the company can earn more profits. In addition, the company must be able to maintain relatively high sales to cover all fixed costs.
Be Aware
The use of operating leverage varies across different industries and business sectors, and the application of Degree of Operating Leverage (DOL) should be adjusted accordingly.
Kane Biotech Degree of Operating Leverage Related Terms
Kane Biotech Degree of Operating Leverage Historical Data
* Premium members only.
The historical data trend for Kane Biotech's Degree of Operating Leverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KNBIF vs VRTX, REGN, ALNY: Degree of Operating Leverage Comparison
For the Biotechnology subindustry, Kane Biotech's Degree of Operating Leverage, along with its competitors' market caps and Degree of Operating Leverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kane Biotech Degree of Operating Leverage vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kane Biotech's Degree of Operating Leverage distribution charts can be found below:
* The bar in red indicates where Kane Biotech's Degree of Operating Leverage falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** TTM data of EBIT and Revenue was used to calculate Degree of Operating Leverage.
*** Please be aware that the Degree of Operating Leverage calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
What does a Degree of Operating Leverage of 0.48 mean?
Kane Biotech (KNBIF) has a Degree of Operating Leverage of 0.48 as of Mar. 2026. Degree of Operating Leverage (DOL) measures the percentage change in EBIT for a unit change in Revenue. View historical data for Kane Biotech and its competitors. According to the industry distribution chart, Kane Biotech ranks #551 out of 853 companies in the Biotechnology industry, placing it in the top 64.6%.
Is Kane Biotech's Degree of Operating Leverage too high?
Kane Biotech's current Degree of Operating Leverage is 0.48. Based on the distribution chart, Kane Biotech ranks #551 out of 853 companies in the Biotechnology industry, which is below the industry midpoint.
How does Kane Biotech's Degree of Operating Leverage compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kane Biotech ranks #551 out of 853 companies for Degree of Operating Leverage. This places Kane Biotech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Degree of Operating Leverage for a Biotechnology company?
A good Degree of Operating Leverage depends on the Biotechnology industry context. However, Degree of Operating Leverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Degree of Operating Leverage mean?
A high Degree of Operating Leverage can signal that a stock is expensive relative to its fundamentals. Degree of Operating Leverage (DOL) measures the percentage change in EBIT for a unit change in Revenue. View historical data for Kane Biotech and its competitors. Kane Biotech's current Degree of Operating Leverage is 0.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kane Biotech stock overvalued right now?
Kane Biotech (KNBIF) has a current Degree of Operating Leverage of 0.48. The current Degree of Operating Leverage is 0.48. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Degree of Operating Leverage calculated?
Degree of Operating Leverage is calculated from a company's financial statements. For Kane Biotech (KNBIF), the current Degree of Operating Leverage is 0.48 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The company's operating segments are animal health and human health. It derives maximum revenue from Animal health segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KNBIF has been successfully added to your 
